Hisamitsu Seiyaku KK header image

Hisamitsu Seiyaku KK

4530

Equity

ISIN JP3784600003 / Valor 761916

Tokyo Stock Exchange (2024-09-18)
JPY 3,910.00-0.74%

Hisamitsu Seiyaku KK
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Hisamitsu Seiyaku KK is a Japanese pharmaceutical company specializing in the development, manufacture, and sale of transdermal drug delivery systems, such as patches.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Sales Growth

Hisamitsu Seiyaku KK reported consolidated net sales of 35,810 million yen for the first quarter of the fiscal year ending February 28, 2025, reflecting an 11.6% increase compared to the same period in the previous year. This growth indicates a positive trend in the company's revenue generation.

Operating Profit Decline

Despite the increase in net sales, Hisamitsu Seiyaku KK experienced a decline in operating profit, which fell by 4.9% year-on-year to 4,149 million yen for the first quarter of the fiscal year ending February 28, 2025. This suggests that the company faced higher operating expenses or other challenges impacting profitability.

Profit Attributable to Owners

The profit attributable to owners of the parent company for Hisamitsu Seiyaku KK in the first quarter of the fiscal year ending February 28, 2025, was 5,562 million yen, a slight decrease of 2.7% compared to the same period in the previous year. This indicates a marginal reduction in the net earnings available to shareholders.

Dividend Forecast

Hisamitsu Seiyaku KK has forecasted an annual dividend of 90.00 yen per share for the fiscal year ending February 28, 2025, which includes a commemorative dividend of 4.00 yen for the 90th anniversary of the launch of SALONPAS®. This represents an increase from the previous year's total dividend of 85.00 yen per share.

Comprehensive Income Surge

Comprehensive income for Hisamitsu Seiyaku KK surged by 85.0% year-on-year to 12,025 million yen for the first quarter of the fiscal year ending February 28, 2025. This significant increase was driven by factors such as foreign currency translation adjustments and valuation differences on available-for-sale securities.

Summarized from source with an LLMView Source

Key figures

-26.7%1Y
-11.4%3Y
-17.6%5Y

Performance

21.2%1Y
27.5%3Y
29.0%5Y

Volatility

Market cap

2353 M

Market cap (USD)

Daily traded volume (Shares)

102,800

Daily traded volume (Shares)

1 day high/low

3961 / 3874

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
11.70%USD 8.02
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.38%USD 2.14
Genetic Technologies Ltd
Genetic Technologies Ltd Genetic Technologies Ltd Valor: 1124821
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
35.71%EUR 0.019
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA SCHOTT Pharma AG & Co. KGaA Valor: 128964250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.27%EUR 31.10
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%CHF 417.50
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.65%CHF 122.40
COLTENE HOLDING AG
COLTENE HOLDING AG COLTENE HOLDING AG Valor: 2534325
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.65%CHF 47.60
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%USD 236.11
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.35%USD 57.70
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.89%USD 6.05